anmelden
Kering Aktie
256,30
EUR
-0,70
EUR
-0,27
%
255,45
EUR
-8,50
EUR
-3,22
%
Kering jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 32,93 Mrd. EUR
KGV 512,51 Div. Rendite 1,00%WKN 851223
ISIN FR0000121485
Symbol PPRUF
AI Analyse
Werbung
Kering Aktie Analyse
| 27.04.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.04.20 | Kering buy | UBS AG | |
| 22.04.20 | Kering overweight | JP Morgan Chase & Co. | |
| 22.04.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.04.20 | Kering buy | Jefferies & Company Inc. | |
| 21.04.20 | Kering Outperform | RBC Capital Markets | |
| 09.04.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.04.20 | Kering Outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 30.03.20 | Kering Conviction Buy | Goldman Sachs Group Inc. | |
| 26.03.20 | Kering buy | UBS AG | |
| 23.03.20 | Kering overweight | JP Morgan Chase & Co. | |
| 23.03.20 | Kering buy | UBS AG | |
| 23.03.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.03.20 | Kering buy | Jefferies & Company Inc. | |
| 09.03.20 | Kering buy | UBS AG | |
| 03.03.20 | Kering Outperform | RBC Capital Markets | |
| 27.02.20 | Kering buy | UBS AG | |
| 21.02.20 | Kering buy | Jefferies & Company Inc. | |
| 14.02.20 | Kering Outperform | RBC Capital Markets | |
| 13.02.20 | Kering buy | Jefferies & Company Inc. | |
| 13.02.20 | Kering buy | UBS AG | |
| 13.02.20 | Kering buy | Kepler Cheuvreux | |
| 12.02.20 | Kering overweight | JP Morgan Chase & Co. | |
| 12.02.20 | Kering buy | Kepler Cheuvreux | |
| 12.02.20 | Kering buy | UBS AG | |
| 12.02.20 | Kering overweight | JP Morgan Chase & Co. | |
| 12.02.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.20 | Kering buy | UBS AG | |
| 29.01.20 | Kering buy | UBS AG | |
| 20.01.20 | Kering buy | Jefferies & Company Inc. | |
| 15.01.20 | Kering buy | Kepler Cheuvreux | |
| 14.01.20 | Kering buy | UBS AG | |
| 13.01.20 | Kering Outperform | RBC Capital Markets | |
| 10.01.20 | Kering overweight | JP Morgan Chase & Co. | |
| 09.01.20 | Kering overweight | JP Morgan Chase & Co. | |
| 09.01.20 | Kering buy | Merrill Lynch & Co., Inc. | |
| 09.01.20 | Kering buy | Merrill Lynch & Co., Inc. | |
| 07.01.20 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.12.19 | Kering buy | UBS AG | |
| 05.12.19 | Kering overweight | JP Morgan Chase & Co. | |
| 05.12.19 | Kering buy | UBS AG | |
| 05.12.19 | Kering buy | Kepler Cheuvreux | |
| 05.12.19 | Kering Outperform | Bernstein Research | |
| 05.12.19 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.12.19 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.19 | Kering Conviction Buy | Goldman Sachs Group Inc. | |
| 30.10.19 | Kering Outperform | RBC Capital Markets | |
| 25.10.19 | Kering buy | UBS AG | |
| 25.10.19 | Kering overweight | JP Morgan Chase & Co. | |
| 25.10.19 | Kering Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung
